- Home
- Pathology Industry
- Endocrine, Nutritional And Metabolic Diseases Market and Forecasts, May 2013
- Endocrine, Nutritional And Metabolic Diseases Market and Forecasts, May 2013
Talk to Sam
+1 917 267 7886
Industries
- Pathology (572)
- Drug and Medication (26)
- Machine Tool and Equipment (21)
- Fish and Seafood (10)
- Biotechnology (9)
-
- Pesticide (8)
- Agriculture (6)
- Agrochemical (6)
- Environmental Services (6)
- Vitamin and Supplement (6)
- Energy & Environment (5)
- Food (5)
- Pharmaceutical (5)
- Tobacco (5)
- Water Distribution and Treatment (5)
- Functional Food (4)
- Petrochemical (4)
- Dairy Products and Egg (3)
- Drug Delivery Technology (3)
- Blood Supply, Tissue Banking and Transplantation (2)
Top countries
Publication dates
All regions
-
- Azerbaijan (3)
- Bangladesh (3)
- Cambodia (1)
- China (23)
- Georgia (4)
- India (48)
- Indonesia (1)
- Iran (4)
- Israel (3)
- Japan (8)
- Jordan (2)
- Kuwait (1)
- Lebanon (2)
- Malaysia (4)
- Mongolia (1)
- Pakistan (3)
- Philippines (3)
- Saudi Arabia (3)
- Singapore (1)
- South Korea (5)
- Sri Lanka (1)
- Syrian Arab Republic (1)
- Taiwan (3)
- Thailand (3)
- Turkey (2)
-
- Australia (25)
- Canada (32)
- Chile (1)
- Czech Republic (1)
- Denmark (4)
- Finland (5)
- France (6)
- Germany (4)
- Ireland (18)
- Israel (3)
- Italy (4)
- Japan (8)
- Luxembourg (1)
- Mexico (2)
- Netherlands (4)
- New Zealand (4)
- Norway (2)
- Poland (4)
- South Korea (5)
- Spain (4)
- Sweden (4)
- Switzerland (5)
- Turkey (2)
- United Kingdom (32)
- United States (343)
data types
- All
- Industry Data
- Company Data (258)
- Country Data (150)
Endocrine, Nutritional And Metabolic Diseases Market and Forecasts, May 2013
You might be interested in: diabete, cardiovascular disease, obesity, more »
industry reports
World Endocrine, Nutritional and Metabolic Diseases Industry Analysis
- Industry report
- October 2011
- 74 pages
... endocrine disorders prevention: how to maintain a healthy weight Policy and environmental change initiatives that make healthy choices in nutrition and physical activity available, affordable ...
The European Pharmaceutical Business
- Industry report
- October 2011
- 30 pages
... Well educated groups typically have: twice the level of chronic illness - heart disease and depression twice as many people out of work due to sickness 50% higher infant mortality more smoking ...
Hypothyroidism Market in India and The United States
- Industry report
- May 2012
- 5 pages
... Religious groups and hormone level (t4, t3 and tsh) etc. Thyroid disorder occur due to iodine deficiency, and clearly more abundant in female than male (p= ...
- Industries: Pathology
- Countries: India, United States
Endocrine, Nutritional and Metabolic Diseases Market (endocrine, nutritional and metabolic diseases, cardiovascular disease) in The United States
- Industry report
- March 2012
- 13 pages
- by Corporation
... Of the antiaging effect of caloric restriction [94]. Nowadays, adipose tissue is recognized as an active metabolic-endocrine organ, and obesity is considered as a low-grade inflammatory condition strongly linked ...
- Industries: Pathology
- Countries: United States
Endocrine, Nutritional and Metabolic Diseases Industry (endocrine, nutritional and metabolic diseases, cardiovascular disease) in The United States and India
- Industry report
- June 2012
- 11 pages
... And activation of glycolysis resulting in increased fat and carbohydrate metabolism and hence increased energy production. The synthetic processes requiring energy expenditure like synthesis of fatty acids ...
- Industries: Pathology
- Countries: United States, India
Pharmaceutical Sector Analysis in The United States
- Industry report
- June 2011
- 126 pages
... He continues to provide care for ihs patients who have chronic kidney disease. A highly recognized nephrologist and public servant, dr. Narva has served as a member of the medical review board ...
- Industries: Pathology
- Countries: United States
Heart Disease Market (heart disease, obesity, diabete) in The United States
- Industry report
- April 2011
- 13 pages
... Saving the 38 billion bucks that congress seems poised to agree upon is not a big deal. A big deal is saving a trillion bucks. And we could do that by preventing disease ...
- Industries: Pathology
- Countries: United States
World Pharmaceutical Business Analysis
- Industry report
- June 2011
- 109 pages
- by Research Paper
... nutrition in global health prepared as part of an education project of the global health education consortium & collaborating partners allan j davison phd, professor, biochemist, faculty ...
World Pharmaceutical Industry Analysis
- Industry report
- June 2011
- 109 pages
- by Research Paper
... nutrition in global health prepared as part of an education project of the global health education consortium & collaborating partners allan j davison phd, professor, biochemist, faculty ...
World Pharmaceutical Industry Analysis
- Industry report
- January 2011
- 106 pages
- by Research Paper
... nutrition in global health prepared as part of an education project of the global health education consortium & collaborating partners allan j davison phd, professor, biochemist, faculty ...
» Purchase Premium Reports (From $ 99 - $ 15 200)
About 500 reports for Endocrine, Nutritional An...
OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017
- $ 5 995
- Industry report
- April 2013
- by Global Data
OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017 Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, ...
» Read our Company Profiles
1 Companies for Endocrine, Nutritional An...AccessEd
AustraliaReportlinker.com © Copyright 2013. All rights reserved.
